$12.75M Securities Settlement Against Cancer Drug Maker Gains Final Approval

Mealey's (June 7, 2022, 12:38 PM EDT) -- SAN DIEGO — A federal judge in California on June 6 granted final approval of a $12.75 million settlement and awarded $4.25 million in attorney fees to class counsel in a...
To view the full article, register now.